Evidence map›Paper›PMID 34440163›Full record

ReviewBiomedicines2021

COVID-19 Disease, Women's Predominant Non-Heparin Vaccine-Induced Thrombotic Thrombocytopenia and Kounis Syndrome: A Passepartout Cytokine Storm Interplay.

Nicholas G Kounis, Ioanna Koniari, Cesare de Gregorio, Stelios F Assimakopoulos, Dimitrios Velissaris, Ming-Yow Hung, Virginia Mplani, Luca Saba, Aikaterini Brinia, Sophia N Kouni and 9 more

Abstract readReview
In one paragraph

Review in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Nicholas G KounisDepartment of Cardiology, University of Patras Medical School, 26221 Patras, Greece.ORCID 0000-0002-9751-6710
Ioanna KoniariDepartment of Cardiology, University Hospital of South Manchester NHS Foundation Trust, Manchester M23 9LT, UK.
Cesare de GregorioDepartment of Clinical and Experimental Medicine, University of Messina Medical School, 98122 Messina, Italy.ORCID 0000-0003-3022-266X
Stelios F AssimakopoulosDepartment of Internal Medicine, University of Patras Medical School, 26500 Patras, Greece.ORCID 0000-0002-6901-3681
Dimitrios VelissarisDepartment of Internal Medicine, University of Patras Medical School, 26500 Patras, Greece.
Ming-Yow HungDivision of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.ORCID 0000-0002-6912-7523
Virginia MplaniIntensive Care Unit, Patras University Hospital, 26500 Patras, Greece.ORCID 0000-0003-1610-0156
Luca SabaDepartment of Radiology, Azienda Ospedaliero Universitaria di Cagliari, 09045 Cagliari, Italy.ORCID 0000-0003-2870-3771
Aikaterini BriniaAllergy Practice, King George Square, 26221 Patras, Greece.
Sophia N KouniSpeech Therapy Practice, Queen Olgas Square, 26221 Patras, Greece.
Christos GogosCovid-19 Unit, Papageorgiou General Hospital, 56403 Thessaloniki, Greece.ORCID 0000-0002-9598-6954
Mattia GiovanniniAllergy Unit, Department of Pediatrics, Meyer Children's University Hospital, 50139 Florence, Italy.ORCID 0000-0001-9568-6882
Elio NovembreAllergy Unit, Department of Pediatrics, Meyer Children's University Hospital, 50139 Florence, Italy.
Vinu ArumughamCisco Systems, Inc., San Jose, CA 95134, USA.
Darrell O RickeGroup 49 Biological and Chemical Technologies, Lincoln Laboratory, Massachusetts Institute of Technology, Lexington, MA 02421, USA.
George D SoufrasDepartment of Cardiology, Saint Andrews State General Hospital, 26221 Patras, Greece.
Kenneth NugentDepartment of Internal Medicine, Texas Technical University Health Sciences Center, Lubbock, TX 79430, USA.
Piero SestiliDepartment of Biomolecular Sciences, Universita degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy.ORCID 0000-0001-9412-1660
Robert W MaloneVaccines and Biotechnology, Scottsville, VA 24590, USA.ORCID 0000-0003-0340-7490

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) constitute one of the deadliest pandemics in modern history demonstrating cardiovascular, gastrointestinal, hematologic, mucocutaneous, respiratory, neurological, renal and testicular manifestations and further complications. COVID-19-induced excessive immune response accompanied with uncontrolled release of cytokines culminating in cytokine storm seem to be the common pathogenetic mechanism of these complications. The aim of this narrative review is to elucidate the relation between anaphylaxis associated with profound hypotension or hypoxemia with pro-inflammatory cytokine release. COVID-19 relation with Kounis syndrome and post-COVID-19 vaccination correlation with heparin-induced thrombocytopenia with thrombosis (HITT), especially serious cerebral venous sinus thrombosis, were also reviewed.

methodsA current literature search in PubMed, Embase and Google databases was performed to reveal the pathophysiology, prevalence, clinical manifestation, correlation and treatment of COVID-19, anaphylaxis with profuse hypotension, Kounis acute coronary syndrome and thrombotic events post vaccination.

resultsThe same key immunological pathophysiology mechanisms and cells seem to underlie COVID-19 cardiovascular complications and the anaphylaxis-associated Kounis syndrome. The myocardial injury in patients with COVID-19 has been attributed to coronary spasm, plaque rupture and microthrombi formation, hypoxic injury or cytokine storm disposing the same pathophysiology with the three clinical variants of Kounis syndrome. COVID-19-interrelated vaccine excipients as polysorbate, polyethelene glycol (PEG) and trometamol constitute potential allergenic substances.

conclusionBetter acknowledgement of the pathophysiological mechanisms, clinical similarities, multiorgan complications of COVID-19 or other viral infections as dengue and human immunodeficiency viruses along with the action of inflammatory cells inducing the Kounis syndrome could identify better immunological approaches for prevention, treatment of the COVID-19 pandemic as well as post-COVID-19 vaccine adverse reactions.

Indexed as

anaphylaxisCOVID-19cytokine stormheparinKounis syndromethrombocytopeniathrombosis

Identifiers

PMID34440163
PMCPMC8391920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.